Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-24Clinical Trial Update: Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine [Phase 3]
Phase 3 study evaluating the Multidimensional Assessment of THYmic States (MATHYS) in bipolar disorder patients treated with olanzapine; the…
-
FDA approval · 2009-06-17FDA Approved: RISPERIDONE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for risperidone, authorizing a generic version of the antipsychotic.
-
CLINICAL_TRIALS trial_result · 2009-06-12Clinical Trial Update: Recovery Guide Intervention for Recurrent Psychiatric Hospitalization [NA]
This clinical trial evaluating a Recovery Guide Intervention for recurrent psychiatric hospitalization has completed, sponsored by Yale Univ…
-
CLINICAL_TRIALS trial_result · 2009-06-02Clinical Trial Update: Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height) [Phase 4]
This Phase 4 trial compared under-the-tongue olanzapine to swallowed olanzapine to evaluate effects on body mass index in patients with schi…
-
CLINICAL_TRIALS trial_result · 2009-06-02Clinical Trial Update: A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression. [Phase 3]
A completed Phase 3 study evaluating the efficacy and safety of Geodon (ziprasidone) in patients with Bipolar I Depression.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-05-29FDA Approved: LAMICTAL XR — Original Application (GlaxoSmithKline LLC)
FDA approved Lamictal XR (lamotrigine) in an original application by GlaxoSmithKline LLC, establishing the extended-release formulation for …
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: Valproic Acid Sodium Salt in Bipolar Disorder [Phase 4]
A Phase 4 clinical trial evaluating valproic acid sodium salt for bipolar disorder has completed, sponsored by Sanofi.
-
FDA approval · 2009-05-27FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for LOXAPINE (loxapine) from Actavis Pharma, Inc., under ANDA072205. This action represents an appro…
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients [Phase 4]
A Phase 4 trial compared adding olanzapine to a mood stabilizer versus a mood stabilizer alone in patients with Bipolar I Disorder; results …
-
CLINICAL_TRIALS trial_result · 2009-05-25Clinical Trial Update: Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
A completed clinical trial update from AstraZeneca describing patient characteristics and treatment approaches for bipolar disorder in Turke…
-
FDA approval · 2009-05-08FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for LAMICTAL (lamotrigine) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2009-05-08FDA Approved: LAMICTAL ODT — Original Application (GlaxoSmithKline LLC)
The FDA approved a new orally disintegrating tablet formulation of lamotrigine (Lamictal ODT). It was approved under GlaxoSmithKline's origi…
-
FDA approval · 2009-04-30FDA Approved: RISPERIDONE — Original Application (Par Health USA, LLC)
FDA approves Par Health USA, LLC's original application for a generic risperidone product, expanding access to the standard indications for …
-
FDA approval · 2009-04-23FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for TEGRETOL (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2009-04-23FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) submitted by Novartis Pharmaceuticals, indicating an approved modifi…
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Effectiveness of Anti-Psychotic in GPs Setting
A completed clinical trial in general practice settings evaluated the effectiveness of an antipsychotic for schizophrenia and bipolar disord…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) [Phase 3]
Phase 3 trial update on safety and tolerability of ziprasidone in children and adolescents with Bipolar I Disorder (manic or mixed) complete…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Investigation of Lithium on Signal Transduction, Gene Expression and Brain Myo-Inositol Levels in Manic Patients [Phase 4]
A Phase 4 clinical trial evaluating the effects of lithium on signal transduction, gene expression, and brain myo-inositol levels in manic p…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of combining quetiapine (Seroquel) with a mood stabilizer for maintenance treatment …
-
FDA label_change · 2009-03-25FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for lamotrigine from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Phase 3 /Seroquel SR Acute Mania Monotherapy - US [Phase 3]
Phase 3 trial evaluating quetiapine extended-release (Seroquel SR) as monotherapy for acute mania in bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-24Clinical Trial Update: A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression [Phase 3]
Phase 3 trial assessing efficacy and safety of Geodon in Bipolar I Depression has completed with results posted in 2009.
-
FDA approval · 2009-03-23FDA Approved: RISPERIDONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for Risperidone from Jubilant Cadista Pharmaceuticals Inc., enabling generic risperidone to be markete…
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms [Phase 3]
This Phase 3 trial evaluated quetiapine as monotherapy for ambulatory bipolar spectrum disorder with moderate-to-severe hypomanic symptoms o…
-
CLINICAL_TRIALS trial_result · 2009-02-27Clinical Trial Update: A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes [Phase 3]
Phase 3 study evaluating the safety and efficacy of injectable risperidone to prevent mood episodes in bipolar disorder; results completed a…